| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Interim Chief Medical Officer
1 company
Douglas Kirk Ways is Interim Chief Medical Officer at SPRB. Douglas Kirk Ways's net worth is not public. Form 4 filings only show shares in the companies where this person is an insider; those holdings are worth an estimated $54K at current prices.
Douglas Kirk Ways has 6 Form 4 filings on record from June 2021 to December 2025, all as Interim Chief Medical Officer at Spruce Biosciences (SPRB), 2021–2025.
The 11 reported transactions were 8 option or other derivative awards, 2 dispositions back to the company and 1 option exercise.
There are no priced open-market purchases or sales on record, so none of these filings shows a decision to buy or sell shares in the market.
No transactions found
Try adjusting your filters or search criteria